SMART-CPT for PTSD/Concussion Implementation
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- PTSD Checklist (PCL5)weekly through treatment completion, an average of 3 months
A brief self-report instrument to measure PTSD symptom severity. It consists of 20 items, scored on a 5-point scale (0 = not at all to 5 = extremely), that correspond to the DSM-5 symptoms of PTSD. It will be used to track PTSD symptom reporting weekly as well as at comprehensive assessments
- Neurobehavioral Symptom Inventory (NSI)weekly through treatment completion, an average of 3 months
A 22 item self-report measure of neurobehavioral symptoms commonly experienced following a mTBI that will be utilized to assess inclusionary cognitive complaints as well as monitor overall neurobehavioral symptoms weekly and at comprehensive assessments.
- The Patient Global Impression of Change (PGIC)at treatment completion, an average of three months
A single-item measure of activity limitations, symptoms, and overall quality of life
- Brief Inventory of Psychosocial Functioning (B-IPF)at 3 primary assessment timepoints, week 0, week 12, week 24
7-item measure of PTSD psychosocial functional impairment
- World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)at 3 primary assessment timepoints; week 0, week 12, week 24
will measure function in the following areas: life activities (work, school, domestic responsibilities), cognition, mobility, self-care, social, and community participation
- Traumatic Brain Injury Quality of Life Scale (TBI-QOL)at 3 primary assessment timepoints; week 0, week 12, week 24
provides comprehensive patient-reported outcomes specific to TBI.